Robert Savino, M.D.

NPI 1700807245ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Danbury, CT

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Danbury, Connecticut, trained at New York College of Osteo Medicine of New York Institute of Technology (class of 1988). Their prescriptions cost Medicare Part D more than their services did: $1,700,718 for 3,269 claims, against $87,814 paid for services in 2024. Sequel Med Tech, LLC was the largest of 3 companies reporting payments in 2025, $63.52 in all, mostly food and beverage.

Overview

NPI	1700807245
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Jul 21, 2006
Last updated in NPPES	Jul 8, 2007

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary	207RE0101X	000429	CT

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Endocrinology (CT)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	423
Services billed	2,454 across 18 procedure codes
Paid by Medicare	$87,814

Part D prescriptions in 2024

Prescriptions (claims)	3,269 · 8,003 30-day fills
Patients	622
Total drug cost	$1,700,718
Generic share	42% of claims

Medicare sources and data years

Education and affiliations

Medical school	New York College of Osteo Medicine of New York Institute of Technology
Graduation year	1988
Medicare specialty	Endocrinology
Telehealth	Offers telehealth